Metacrine's Series A Round

Metacrine raised a round of funding on August 05, 2015.

Metacrine is a biotechnology company focused on developing drugs that materially benefit patients with liver, gastrointestinal, and metabolic diseases. Metacrine's lead program for non-alcoholic steat…

Articles about Metacrine's Series A Round: